PPARG and colorectal cancer: Other groups have also determined this involvement: exposure ofcultured human colorectal cancer cell lines to PPARγ agonistsinhibits growth, associated with G1 cell cycle arrest, and it increasesseveral markers of differentiation [25, 26].